SHANNON DUFRENE: Open Payments
NPI 1295187847 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 4 payments from 4 companies in 2025. Trend: 2023 $145 · 2024 $484 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $147 |
| Edwards Lifesciences Corporation | 1 | $125 |
| GENZYME CORPORATION | 1 | $120 |
| ABBVIE INC. | 1 | $97 |
Products named: REZDIFFRA, FABRAZYME, VRAYLAR.
Industry payments across LA — which companies pay providers there.
